dehydroepiandrosterone sulfate has been researched along with Bone Cancer in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kagawa, M; Kawakami, S; Morozumi, M; Okada, Y; Takeshita, H; Yano, A | 1 |
| Sasagawa, I; Satomi, S | 1 |
| Belanger, A; Bergeron, V; Dupont, A; Emond, J; Giguere, M; Labrie, F; Lacoursiere, Y; Monfette, G | 1 |
1 trial(s) available for dehydroepiandrosterone sulfate and Bone Cancer
| Article | Year |
|---|---|
Combination therapy with flutamide and castration (LHRH agonist or orchiectomy) in advanced prostate cancer: a marked improvement in response and survival.
Topics: Acid Phosphatase; Anilides; Bone and Bones; Bone Neoplasms; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Drug Therapy, Combination; Flutamide; Gonadotropin-Releasing Hormone; Humans; Male; Orchiectomy; Prostatic Neoplasms; Radionuclide Imaging; Testosterone | 1985 |
2 other study(ies) available for dehydroepiandrosterone sulfate and Bone Cancer
| Article | Year |
|---|---|
Baseline low serum dehydroepiandrosterone sulfate can predict poor responsiveness to hormone therapy in patients with hormone-naïve prostate cancer with skeletal metastases.
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Anilides; Bone Neoplasms; Dehydroepiandrosterone Sulfate; Humans; Male; Middle Aged; Nitriles; Predictive Value of Tests; Prostatic Neoplasms; Tosyl Compounds | 2017 |
Effect of high-dose medroxyprogesterone acetate on plasma hormone levels and pain relief in patients with advanced prostatic cancer.
Topics: Adrenocorticotropic Hormone; Aged; Antineoplastic Agents; Bone Neoplasms; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Follicle Stimulating Hormone; Gonadotropins; Growth Hormone; Humans; Hydrocortisone; Luteinizing Hormone; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Palliative Care; Prolactin; Prostatic Neoplasms; Thyrotropin | 1990 |